303 KB21 KB202220252024Rebernak, Špelaštevilka:3str. 45-48COBISSID_HOST:208904195ISSN:2820-5014URN:URN:NBN:SI:doc-PY4TCGSGslFakulteta za farmacijo, ŠSSFDPlaceboAlzheimerjeva bolezenkinolilnitroniNevrodegenerativne bolezniParkinsonova bolezenKinolilnitroni – večtarčne učinkovine za terapijo nevrodegenerativnih bolezni|Neurodegenerative diseases are a diverse group of diseases that affect a large number of people worldwide. It is characterised by the involvement of the central and peripheral nervous system. For many years, established synthetic agents have been used for treatment, but increasingly, phytopharmaceuticals are also being introduced into therapy, with many favourable results and fewer side effects. These are very common in mainstream medicines and have a major impact on the quality of life of patients, and a lot of attention is being focused on the further development of these therapeutic agentsNevrodegenerativne bolezni so raznolika skupina bolezni, ki prizadene veliko število ljudi po svetu. Značilna je prizadetost centralnega in perifernega živčnega sistema. Za zdravljenje se že vrsto let uporabljajo uveljavljene sintezne učinkovine, vse bolj pa v terapijo prihajajo tudi fitofarmaki, ki kažejo mnogo ugodnih rezultatov in manj neželenih učinkov. Ti so pri splošno razširjenih zdravilih zelo pogosti in močno vplivajo na kakovost življenja pacientov, zato je veliko pozornosti usmerjene v nadaljnji razvoj teh terapevtskih možnostiTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of Slovenia